pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.
pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.
复制标题
DOI:
10.1016/j.jconrel.2015.01.005
复制
发表时间:
2015-05-10
影响因子:
10.8
通讯作者:
Yun, Chae-Ok
中科院分区:
文献类型:
--
作者:
Choi, Joung-Woo;Jung, Soo-Jung;Kasala, Dayananda;Hwang, June Kyu;Hu, Jun;Bae, You Han;Yun, Chae-Ok
关键词:
Although oncolytic adenoviruses (Ads) are an attractive option for cancer gene therapy, the intravenous administration of naked Ad still encounters unfavorable host responses, non-specific interactions, and heterogeneity in targeted cancer cells. To overcome these obstacles and achieve specific targeting of the tumor microenvironment, Ad was coated with the pH-sensitive block copolymer, methoxy poly(ethylene glycol)-b-poly(l-histidine-co-l-phenylalanine) (PEGbPHF). The physicochemical properties of the generated nanocomplex, Ad/PEGbPHF, were assessed. At pH 6.4, GFP-expressing Ad/PEGbPHF induced significantly higher GFP expression than naked Ad in both coxsackie and adenovirus receptor (CAR)-positive and -negative cells. To assess the therapeutic efficacy of the Ad/PEGbPHF complex platform, an oncolytic Ad expressing VEGF promoter-targeting transcriptional repressor (KOX) was used to form complexes. At pH 6.4, KOX/PEGbPHF significantly suppressed VEGF gene expression, cancer cell migration, vessel sprouting, and cancer cell killing effect compared to naked KOX or KOX/PEGbPHF at pH 7.4, demonstrating that KOX/PEGbPHF can overcome the lack of CAR that is frequently observed in tumor tissues. The antitumor activity of KOX/PEGbPHF systemically administered to a tumor xenograft model was significantly higher than that of naked KOX. Furthermore, KOX/PEGbPHF showed lower hepatic toxicity and did not induce an innate immune response against Ad. Altogether, these results demonstrate that pH-sensitive polymer-coated Ad complex significantly increases net positive charge upon exposure to hypoxic tumor microenvironment, allowing passive targeting to the tumor tissue. It may offer superior potential for systemic therapy, due to its improved tumor selectivity, increased therapeutic efficacy, and lower toxicity compared to naked KOX.
登录
查看更多内容
DOI:
10.1016/j.jconrel.2012.04.014
发表时间:
2012-12-10
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
Denison TA;Bae YH
通讯作者:
Bae YH
影响因子:
5.1
作者:
Baker, A;Saltik, M;Cotten, M
通讯作者:
Cotten, M
影响因子:
3.7
作者:
GREEN, M;DAESCH, GE
通讯作者:
DAESCH, GE
影响因子:
4.7
作者:
Chang, Kai-Ling;Higuchi, Yuriko;Hashida, Mitsuru
通讯作者:
Hashida, Mitsuru
影响因子:
15.9
作者:
Heise, C;Kirn, DH
通讯作者:
Kirn, DH